Ok-Jin Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ok-Jin Jang has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Seon-Cheol Park
Department of Psychiatry, Hanyang University College of Medicine, Seoul, Republic of Korea
10 shared publications - Naotaka Shinfuku
School of Human Sciences, Seinan Gakuin University, Fukuoka, Japan
5 shared publications - Jung Goo Lee
Paik Institute for Clinical Research, Inje University, Busan, Korea
4 shared publications - Shih-Ku Lin
Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
4 shared publications - Chay Hoon Tan
Department of Pharmacology, National University Hospital, Singapore, Singapore
3 shared publications - Kiwon Kim
Workplace Mental Health Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants
Won-Seok Choi, MoonSoo Lee, Mi Kyoung Seo, Og-Jin Jang, Jung Goo Lee. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.26.1457
- 31 July 2026
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
Open AccessPsychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants
Won-Seok Choi, MoonSoo Lee, Mi Kyoung Seo, Og-Jin Jang, Jung Goo Lee. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.26.1457
- Open Access
- 24 November 2025
- Published by Akademiai Kiado Zrt. in Journal of Psychedelic Studies
- Vol. 9 (4) , 385-394
Knowledge and attitudes about the use of psychedelic drugs among psychiatric professionals in Korea
Background and aims: A mental health professional's background regarding psychedelics, including their attitudes, is important to the therapeutic effects of these drugs; however, no study has examined this in Asian populations. This study aims to evaluate the knowledge and attitudes of psychiatric professionals in Korea regarding the use of psychedelics in clinical practice. Methods: An anonymous survey consisting of 15 questions was distributed to 200 participants at three academic psychiatric conferences in Korea. The survey assessed participants' knowledge of the history, mechanisms, and therapeutic potential of psychedelic drugs, as well as their attitudes towards their legalization and usage for psychiatric treatment. Results: The survey had a 96.5% response rate (193/200), with 44% (85/193) of respondents being psychiatry residents. Disparities in prior knowledge of psychedelics, especially in their mechanisms of action, were found between residents and psychiatrists. Despite this, for all participants, there was a notable interest in the potential therapeutic applications of psychedelics, particularly for conditions that are difficult to treat, such as depression and post-traumatic stress disorder. Additionally, positive attitudes toward psychedelics were lower among women, with most respondents expressing a cautious optimism about the future integration of psychedelics into psychiatric practice, contingent upon further research and regulatory approval. Conclusions: The study underscores the need for enhanced education and training on psychedelic drugs within the Korean psychiatric community. Increasing awareness and understanding of these substances could help align Korean psychiatric practices with global trends in fields of psychedelics and potentially improve treatment outcomes for patients with severe and refractory psychiatric conditions.
- 24 November 2025
- Published by Akademiai Kiado Zrt. in Journal of Psychedelic Studies
- Vol. 9 (4) , 385-394
Open AccessKnowledge and attitudes about the use of psychedelic drugs among psychiatric professionals in Korea
Background and aims: A mental health professional's background regarding psychedelics, including their attitudes, is important to the therapeutic effects of these drugs; however, no study has examined this in Asian populations. This study aims to evaluate the knowledge and attitudes of psychiatric professionals in Korea regarding the use of psychedelics in clinical practice. Methods: An anonymous survey consisting of 15 questions was distributed to 200 participants at three academic psychiatric conferences in Korea. The survey assessed participants' knowledge of the history, mechanisms, and therapeutic potential of psychedelic drugs, as well as their attitudes towards their legalization and usage for psychiatric treatment. Results: The survey had a 96.5% response rate (193/200), with 44% (85/193) of respondents being psychiatry residents. Disparities in prior knowledge of psychedelics, especially in their mechanisms of action, were found between residents and psychiatrists. Despite this, for all participants, there was a notable interest in the potential therapeutic applications of psychedelics, particularly for conditions that are difficult to treat, such as depression and post-traumatic stress disorder. Additionally, positive attitudes toward psychedelics were lower among women, with most respondents expressing a cautious optimism about the future integration of psychedelics into psychiatric practice, contingent upon further research and regulatory approval. Conclusions: The study underscores the need for enhanced education and training on psychedelic drugs within the Korean psychiatric community. Increasing awareness and understanding of these substances could help align Korean psychiatric practices with global trends in fields of psychedelics and potentially improve treatment outcomes for patients with severe and refractory psychiatric conditions.
- 9 June 2025
- Published by Wiley in Asia-Pacific Psychiatry
- Vol. 17 (2) , e70004
Adjunctive Antidepressant Use in Bipolar Disorder and Its Clinical Correlates: An Asian Psychotropic Prescription Patterns Consortium Study
Introduction: Adjunctive antidepressant (AD) use is prevalent for the treatment of bipolar disorder (BD) in many countries, but there is little information about this practice in Asia. Accordingly, we addressed the prevalence, dosing, and clinical correlates of adjunctive AD use with BD in a large Asian sample.Methods: Patients with BD were recruited across 13 Asian sites (PR China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, and Thailand) for this cross‐sectional study. We examined differences between patients with versus without adjunctive AD treatment. Multivariable logistic regression was used to identify factors associated with the use of adjunctive AD.Results: Among a total of 2114 adult participants (47.7% men; age 42.4 years [CI: 41.8–43.0]; BMI 25.0 kg/m2 [24.8–25.2]), the prevalence of AD use averaged 19.8% [18.1–21.6], at a mean imipramine‐equivalent dose of 113 [110–116] mg/day. Adjunctive AD use was associated with factors including older age, outpatient status, more depression, suicidal behavior, rapid cycling, and lower doses of MS and antipsychotics (APs).Discussion: Usage of AD treatment for BD in Asia was less than half that reported in Western samples. Such use of AD treatment appeared to be well tolerated but underscores the need for close clinical follow‐up to avoid risks of excessive elevation of mood or behavior.
- 9 June 2025
- Published by Wiley in Asia-Pacific Psychiatry
- Vol. 17 (2) , e70004
Adjunctive Antidepressant Use in Bipolar Disorder and Its Clinical Correlates: An Asian Psychotropic Prescription Patterns Consortium Study
Introduction: Adjunctive antidepressant (AD) use is prevalent for the treatment of bipolar disorder (BD) in many countries, but there is little information about this practice in Asia. Accordingly, we addressed the prevalence, dosing, and clinical correlates of adjunctive AD use with BD in a large Asian sample.Methods: Patients with BD were recruited across 13 Asian sites (PR China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, and Thailand) for this cross‐sectional study. We examined differences between patients with versus without adjunctive AD treatment. Multivariable logistic regression was used to identify factors associated with the use of adjunctive AD.Results: Among a total of 2114 adult participants (47.7% men; age 42.4 years [CI: 41.8–43.0]; BMI 25.0 kg/m2 [24.8–25.2]), the prevalence of AD use averaged 19.8% [18.1–21.6], at a mean imipramine‐equivalent dose of 113 [110–116] mg/day. Adjunctive AD use was associated with factors including older age, outpatient status, more depression, suicidal behavior, rapid cycling, and lower doses of MS and antipsychotics (APs).Discussion: Usage of AD treatment for BD in Asia was less than half that reported in Western samples. Such use of AD treatment appeared to be well tolerated but underscores the need for close clinical follow‐up to avoid risks of excessive elevation of mood or behavior.
- Open Access
- 30 May 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (5) , 725-734
Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study
Gwang Hyeon Choi, Young-Hoon Chon, Do Hoon Kwon, Sung Nam Jo, Og-Jin Jang, Kyung-Ah Kim, Dahye Baik, Eun Sun Jang, Sook-Hyang Jeong. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240451
- 30 May 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (5) , 725-734
Open AccessPrevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study
Gwang Hyeon Choi, Young-Hoon Chon, Do Hoon Kwon, Sung Nam Jo, Og-Jin Jang, Kyung-Ah Kim, Dahye Baik, Eun Sun Jang, Sook-Hyang Jeong. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240451
- Open Access
- 28 April 2023
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 85, 103613
Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study
- 28 April 2023
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 85, 103613
Open AccessClinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study
- Open Access
- 31 March 2023
- Published by Korean Society for Affective Disorders in Mood and Emotion
- Vol. 21 (1) , 8-17
Relationship Between Subjective Body Shape Perception and Depression Screening Tool PHQ-9 in the Geriatric Population: The Korean National Health and Nutrition Examination Survey
Woo Seok Cheon, MD, Gyung-Mee Kim, MD, PhD, Taekjoong Kim, MD, PhD, Jung Goo Lee, MD, PhD, Ok-Jin Jang, MD, PhD. Mood Emot 2023;21:8-17. https://doi.org/10.35986/me.2023.21.1.8
- 31 March 2023
- Published by Korean Society for Affective Disorders in Mood and Emotion
- Vol. 21 (1) , 8-17
Open AccessRelationship Between Subjective Body Shape Perception and Depression Screening Tool PHQ-9 in the Geriatric Population: The Korean National Health and Nutrition Examination Survey
Woo Seok Cheon, MD, Gyung-Mee Kim, MD, PhD, Taekjoong Kim, MD, PhD, Jung Goo Lee, MD, PhD, Ok-Jin Jang, MD, PhD. Mood Emot 2023;21:8-17. https://doi.org/10.35986/me.2023.21.1.8
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (48) , e357
Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012–2022: A Multicenter, Retrospective Study
Kim J, et al. J Korean Med Sci. 2023 Nov;38:e357. https://doi.org/10.3346/jkms.2023.38.e357
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (48) , e357
Open AccessHepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012–2022: A Multicenter, Retrospective Study
Kim J, et al. J Korean Med Sci. 2023 Nov;38:e357. https://doi.org/10.3346/jkms.2023.38.e357
- Open Access
- 14 June 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (6) , 969
Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia
The augmentation of clozapine with electroconvulsive therapy (ECT) has been an optimal treatment option for patients with treatment- or clozapine-resistant schizophrenia. Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics survey, which was the largest international psychiatry research collaboration in Asia, our study aimed to develop a machine learning algorithm-based substantial prediction model for the augmented use of clozapine with ECT in patients with schizophrenia in terms of precision medicine. A random forest model and least absolute shrinkage and selection operator (LASSO) model were used to develop a substantial prediction model for the augmented use of clozapine with ECT. Among the 3744 Asian patients with schizophrenia, those treated with a combination of clozapine and ECT were characterized by significantly greater proportions of females and inpatients, a longer duration of illness, and a greater prevalence of negative symptoms and social or occupational dysfunction than those not treated. In the random forest model, the area under the curve (AUC), which was the most preferred indicator of the prediction model, was 0.774. The overall accuracy was 0.817 (95% confidence interval, 0.793–0.839). Inpatient status was the most important variable in the substantial prediction model, followed by BMI, age, social or occupational dysfunction, persistent symptoms, illness duration > 20 years, and others. Furthermore, the AUC and overall accuracy of the LASSO model were 0.831 and 0.644 (95% CI, 0.615–0.672), respectively. Despite the subtle differences in both AUC and overall accuracy of the random forest model and LASSO model, the important variables were commonly shared by the two models. Using the machine learning algorithm, our findings allow the development of a substantial prediction model for the augmented use of clozapine with ECT in Asian patients with schizophrenia. This substantial prediction model can support further studies to develop a substantial prediction model for the augmented use of clozapine with ECT in patients with schizophrenia in a strict epidemiological context.
- 14 June 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (6) , 969
Open AccessMachine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia
The augmentation of clozapine with electroconvulsive therapy (ECT) has been an optimal treatment option for patients with treatment- or clozapine-resistant schizophrenia. Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics survey, which was the largest international psychiatry research collaboration in Asia, our study aimed to develop a machine learning algorithm-based substantial prediction model for the augmented use of clozapine with ECT in patients with schizophrenia in terms of precision medicine. A random forest model and least absolute shrinkage and selection operator (LASSO) model were used to develop a substantial prediction model for the augmented use of clozapine with ECT. Among the 3744 Asian patients with schizophrenia, those treated with a combination of clozapine and ECT were characterized by significantly greater proportions of females and inpatients, a longer duration of illness, and a greater prevalence of negative symptoms and social or occupational dysfunction than those not treated. In the random forest model, the area under the curve (AUC), which was the most preferred indicator of the prediction model, was 0.774. The overall accuracy was 0.817 (95% confidence interval, 0.793–0.839). Inpatient status was the most important variable in the substantial prediction model, followed by BMI, age, social or occupational dysfunction, persistent symptoms, illness duration > 20 years, and others. Furthermore, the AUC and overall accuracy of the LASSO model were 0.831 and 0.644 (95% CI, 0.615–0.672), respectively. Despite the subtle differences in both AUC and overall accuracy of the random forest model and LASSO model, the important variables were commonly shared by the two models. Using the machine learning algorithm, our findings allow the development of a substantial prediction model for the augmented use of clozapine with ECT in Asian patients with schizophrenia. This substantial prediction model can support further studies to develop a substantial prediction model for the augmented use of clozapine with ECT in patients with schizophrenia in a strict epidemiological context.
- Open Access
- 28 February 2022
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 20 (1) , 61-69
Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder
Shih-Ku Lin, Shu-Yu Yang, Seon-Cheol Park, Ok-Jin Jang, Xiaomin Zhu, Yu-Tao Xiang, Wen-Chen Ouyang, Afzal Javed, M. Nasar Sayeed Khan, Sandeep Grover, Ajit Avasthi, Roy Abraham Kallivayalil, Kok Yoon Chee, Norliza Chemi, Takahiro A. Kato, Kohei Hayakawa, Pornjira Pariwatcharakul, Margarita Maramis, Lakmi Seneviratne, Sim Kang, Wai Kwong Tang, Tin Oo, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park, Naotaka Shinfuku. Clin Psychopharmacol Neurosci 2022;20:61-9. https://doi.org/10.9758/cpn.2022.20.1.61
- 28 February 2022
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 20 (1) , 61-69
Open AccessPrescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder
Shih-Ku Lin, Shu-Yu Yang, Seon-Cheol Park, Ok-Jin Jang, Xiaomin Zhu, Yu-Tao Xiang, Wen-Chen Ouyang, Afzal Javed, M. Nasar Sayeed Khan, Sandeep Grover, Ajit Avasthi, Roy Abraham Kallivayalil, Kok Yoon Chee, Norliza Chemi, Takahiro A. Kato, Kohei Hayakawa, Pornjira Pariwatcharakul, Margarita Maramis, Lakmi Seneviratne, Sim Kang, Wai Kwong Tang, Tin Oo, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park, Naotaka Shinfuku. Clin Psychopharmacol Neurosci 2022;20:61-9. https://doi.org/10.9758/cpn.2022.20.1.61
- Open Access
- 25 July 2021
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 18 (7) , 701-707
Lifestyle Changes that Impact Personal Quality of Life in the COVID-19 Pandemic in South Korea
Objective We investigated which factors in psychological changes positively or negatively affect the quality of life to suggest desirable directions in the period of the COVID-19 pandemic.Methods Online survey was conducted with 1,011 adults more than 19 years old in Busan, South Korea. Quality of life was measured using the World Health Organization Quality of Life-BREF. Questions regarding the psychological changes were about COVID-19-related concerns, distress in complying with quarantine guidelines, and interest in seeking something to do alone.Results Quality of life was perceived to be below average (mean±SD, 2.86±0.53). The more economic worries there were, the lower the quality of life in psychological, social relationships and environmental domains. The more distress one experienced when maintaining their personal hygiene, the higher the quality of life related to their physical health. Likewise, the more difficult it was to maintain social distances, the higher the quality of life associated with psychological and social relationships. The more interested someone was in how to spend time alone, the higher the quality of life in all domains significantly.Conclusion We can minimize the negative impacts of COVID-19 by maintaining economic stability, maintaining prosocial behaviors related to personal hygiene and making good use of personal time.
- 25 July 2021
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 18 (7) , 701-707
Open AccessLifestyle Changes that Impact Personal Quality of Life in the COVID-19 Pandemic in South Korea
Objective We investigated which factors in psychological changes positively or negatively affect the quality of life to suggest desirable directions in the period of the COVID-19 pandemic.Methods Online survey was conducted with 1,011 adults more than 19 years old in Busan, South Korea. Quality of life was measured using the World Health Organization Quality of Life-BREF. Questions regarding the psychological changes were about COVID-19-related concerns, distress in complying with quarantine guidelines, and interest in seeking something to do alone.Results Quality of life was perceived to be below average (mean±SD, 2.86±0.53). The more economic worries there were, the lower the quality of life in psychological, social relationships and environmental domains. The more distress one experienced when maintaining their personal hygiene, the higher the quality of life related to their physical health. Likewise, the more difficult it was to maintain social distances, the higher the quality of life associated with psychological and social relationships. The more interested someone was in how to spend time alone, the higher the quality of life in all domains significantly.Conclusion We can minimize the negative impacts of COVID-19 by maintaining economic stability, maintaining prosocial behaviors related to personal hygiene and making good use of personal time.